BSE Live
Apr 20, 16:01Prev. Close
3.28
Open Price
3.23
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Cash Flow of Zenith Healthcare (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 0.28 | 0.28 | 0.12 | 0.61 | 0.59 | |
| Net CashFlow From Operating Activities | 0.67 | 1.74 | -0.92 | 1.32 | -1.47 | |
| Net Cash Used In Investing Activities | -1.09 | -0.11 | -0.03 | -0.23 | -0.19 | |
| Net Cash Used From Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -0.41 | 1.63 | -0.95 | 1.09 | -1.65 | |
| Cash And Cash Equivalents Begin of Year | 0.78 | 0.92 | 1.87 | 0.78 | 2.43 | |
| Cash And Cash Equivalents End Of Year | 0.36 | 2.55 | 0.92 | 1.87 | 0.78 |
12.11.2025
Zenith Health Standalone September 2025 Net Sales at Rs 2.27 crore, down 25.14% Y-o-Y
05.06.2025
Zenith Health Standalone March 2025 Net Sales at Rs 3.43 crore, up 11.58% Y-o-Y
17.02.2025
Zenith Health Standalone December 2024 Net Sales at Rs 2.31 crore, down 40.76% Y-o-Y
25.10.2024
Zenith Health Standalone September 2024 Net Sales at Rs 3.03 crore, down 13.33% Y-o-Y
12.11.2025
Zenith Health Standalone September 2025 Net Sales at Rs 2.27 crore, down 25.14% Y-o-Y
05.06.2025
Zenith Health Standalone March 2025 Net Sales at Rs 3.43 crore, up 11.58% Y-o-Y
17.02.2025
Zenith Health Standalone December 2024 Net Sales at Rs 2.31 crore, down 40.76% Y-o-Y
25.10.2024
Zenith Health Standalone September 2024 Net Sales at Rs 3.03 crore, down 13.33% Y-o-Y
13.04.2026
13.04.2026
10.04.2026
09.04.2026
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth